From the Guidelines
Coenzyme Q10 (CoQ10) is not recommended for routine use in patients treated with statins or for the treatment of statin-associated muscle symptoms (SAMS). This recommendation is based on the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol, which states that available evidence does not support the use of CoQ10 supplementation for routine use in patients treated with statins or for the treatment of SAMS 1. The guideline suggests that the majority of SAMS are subjective myalgia in the absence of other findings, and an asymptomatic increase in transaminases is an infrequent statin-associated side effect. Therefore, CoQ10 supplementation is not necessary for most patients taking statins, and routine measurements of creatine kinase and transaminase levels are not useful in patients treated with statins 1.
Some key points to consider:
- Statins can deplete the body's natural CoQ10 levels, but supplementing with CoQ10 may not be necessary for most patients.
- CoQ10 is important for cellular energy production, particularly in muscle cells, but available evidence does not support its use for routine use in patients treated with statins or for the treatment of SAMS.
- Patients with statin-associated side effects should be reassessed and rechallenged with a reduced dose, alternative agent, or alternative dosing regimen while monitoring for recurrent symptoms.
- Nonstatin therapy should be considered in patients at increased ASCVD risk with severe statin-associated muscle symptoms or recurrent SAMS despite appropriate statin rechallenge.
It's essential to consult with a doctor before starting any new supplement, especially if you're taking medications, as CoQ10 can interact with some drugs, including blood thinners.
From the Research
CoQ10 Supplementation for Statin Users
- The effectiveness of CoQ10 supplementation for statin-induced myopathy is a topic of ongoing research, with studies yielding conflicting results 2, 3, 4, 5, 6.
- Some studies suggest that CoQ10 supplementation may ameliorate statin-associated muscle symptoms, such as muscle pain, weakness, cramp, and tiredness 4, 6.
- However, other studies have found no significant benefit of CoQ10 supplementation in improving statin-induced myopathy, with no reduction in muscle pain or plasma creatine kinase levels 3, 5.
- A systematic review of randomized controlled trials found that CoQ10 supplementation significantly ameliorates statin-induced musculoskeletal symptoms, but another meta-analysis found no significant benefit 4, 5.
- The use of CoQ10 supplementation in statin users is not universally recommended, and its effectiveness may depend on individual patient factors and the specific statin being used 2, 3, 4, 5, 6.
Key Findings
- A 2015 study found that CoQ10 supplementation did not reduce muscle pain in patients with statin myalgia 3.
- A 2024 systematic review found that CoQ10 supplementation significantly ameliorates statin-induced musculoskeletal symptoms 4.
- A 2022 meta-analysis found that CoQ10 supplementation did not have a significant benefit in improving statin-induced myopathy 5.
- A 2018 meta-analysis found that CoQ10 supplementation ameliorated statin-associated muscle symptoms, such as muscle pain, weakness, cramp, and tiredness 6.